
Ribavirin Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules and Oral Solution
Available Strengths: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
Category: Hepatitis
Ribavirin is available in Tablets, Capsules and Oral Solution and strengths such as Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ribavirin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ribavirin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Ribavirin is a broad-spectrum antiviral used in combination with other agents, such as Interferon Alfa or Sofosbuvir, for the treatment of chronic Hepatitis C virus (HCV) infection. Available in oral capsule and tablet forms, Ribavirin enhances antiviral efficacy by inhibiting viral RNA replication. It is commonly prescribed in combination regimens to improve sustained virologic response (SVR) in HCV patients. Ribavirin is FDA and EMA approved and marketed under various brands like Rebetol® and Copegus®. It remains a key product in pharma B2B hepatitis portfolios for both US and EU healthcare markets, particularly in resource-limited or genotype-specific treatment settings.
Frequently Asked Questions
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsGlecaprevir/Pibrentasvir
Strength: Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View DetailsAdefovir Dipivoxil
Strength: 10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsTenofovir Alafenamide (Taf)
Strength: 25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers